ContraFect Inc. (CFRX) stock declines during premarket session. Here’s what you should know?

DPRO Stock

ContraFect Inc. (NASDAQ: CFRX) stock gained by 5.38% at last close whereas the CFRX stock price plunged by 7.65% during the pre market session, at last check. ContraFect is a pharmaceutical corporation specializing in the research and production of DLAs, such as lysins and amurin peptides, as novel medicinal treatments for life-threatening, antibiotic-resistant infections. CFRX […]